• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Hims & Hers Health Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket

    8/8/23 8:20:19 AM ET
    $AYX
    $BPTS
    $BTTR
    $BYND
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AYX alert in real time by email

    Gainers

    • Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) shares surged 83.5% to $0.1648 in pre-market trading after falling over 25% on Monday. The company recently announced its plans to reduce the company's headcount by 78%.
    • Biophytis S.A. (NASDAQ:BPTS) rose 59.4% to $2.47 in pre-market trading as the company received positive opinion from Belgian authorities for its SARA-31 Phase 3 study.
    • Vivos Therapeutics, Inc. (NASDAQ:VVOS) shares rose 38% to $0.3601 in pre-market trading after falling more than 10% on Monday.
    • Chegg, Inc. (NYSE:CHGG) gained 23.4% to $12.39 in pre-market trading after reporting better-than-expected quarterly sales.
    • Galera Therapeutics, Inc. (NASDAQ:GRTX) shares gained 18.4% to $2.57 in pre-market trading.
    • Cardiff Oncology, Inc. (NASDAQ:CRDF) shares rose 17.2% to $1.84 in pre-market trading after the company announced new lead program in first-line metastatic colorectal cancer and expanded Pfizer relationship.
    • Hims & Hers Health, Inc. (NASDAQ:HIMS) shares climbed 17.2% to $9.26 in pre-market trading after the company posted upbeat second-quarter results and raised full-year revenue forecast.
    • Paymentus Holdings, Inc. (NYSE:PAY) shares gained 13.4% to $12.13 in pre-market trading after reporting better-than-expected quarterly results.
    • Better Choice Company Inc. (NYSE:BTTR) rose 12.6% to $0.29 in pre-market trading after jumping 16% on Monday.
    • Viant Technology Inc. (NASDAQ:DSP) gained 11.8% to $5.12 in pre-market trading following strong quarterly results.

    Losers

    • Proterra Inc. (NASDAQ:PTRA) fell 63% to $0.5293 in pre-market trading. Proterra filed for Chapter 11 bankruptcy protection on Monday citing market and macroeconomic headwinds.
    • Datasea Inc. (NASDAQ:DTSS) shares fell 28.8% to $0.8122 in pre-market trading. Datasea said on August 1 that it entered into two separate subscription agreements with a certain non-U.S. investor to sell an aggregate of 4.8 million shares of common stock at $1.20 per share.
    • Alteryx, Inc. (NYSE:AYX) fell 25% to $28.22 in pre-market trading after the company reported second-quarter results and issued weak third-quarter revenue guidance. Piper Sandler downgraded to Neutral from Overweight and lowered the price target to $30 from $68.
    • Missfresh Limited (NASDAQ:MF) fell 23.3% to $2.00 in pre-market trading after jumping around 32% on Monday.
    • International Flavors & Fragrances Inc. (NYSE:IFF) shares fell 21.6% to $63.00 in pre-market trading after the company reported worse-than-expected second-quarter results and issued a reduced FY23 outlook.
    •  
    • Save Foods, Inc. (NASDAQ:SVFD) fell 21.2% to $1.23 in pre-market after jumping 144% on Monday.
    • ParaZero Technologies Ltd. (NASDAQ:PRZO) fell 17.2% to $1.73 in pre-market trading. ParaZero shares jumped 40% on Monday after the company received a second order for its custom safety system for drones by an automotive manufacturer.
    • GreenPower Motor Company Inc. (NASDAQ:GP) shares fell 16.4% to $3.22 in pre-market trading after declining around 5% on Monday.
    • Beyond Meat, Inc. (NASDAQ:BYND) fell 16% to $12.84 in pre-market trading after the company reported downbeat results for its second quarter and issued weak revenue forecast for FY23.
    • Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) fell 15.4% to $9.32 in pre-market trading after the company posted downbeat second-quarter sales and issued weak FY23 forecast.

     

    Now Read This: Eli Lilly, Beyond Meat And 3 Stocks To Watch Heading Into Tuesday

    Get the next $AYX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AYX
    $BPTS
    $BTTR
    $BYND

    CompanyDatePrice TargetRatingAnalyst
    Hims & Hers Health Inc.
    $HIMS
    3/10/2026$24.00Sell → Neutral
    Citigroup
    Hims & Hers Health Inc.
    $HIMS
    3/10/2026$23.00Underperform → Neutral
    BofA Securities
    Hims & Hers Health Inc.
    $HIMS
    3/9/2026$30.00Hold → Buy
    Needham
    Hims & Hers Health Inc.
    $HIMS
    2/24/2026Buy → Neutral
    BTIG Research
    Paymentus Holdings Inc.
    $PAY
    2/20/2026$35.00Outperform → Strong Buy
    Raymond James
    International Flavors & Fragrances Inc.
    $IFF
    2/13/2026$97.00Perform → Outperform
    Oppenheimer
    Hims & Hers Health Inc.
    $HIMS
    1/12/2026$33.00In-line
    Evercore ISI
    Cardiff Oncology Inc.
    $CRDF
    1/5/2026$12.00Outperform
    Noble Capital Markets
    More analyst ratings

    $AYX
    $BPTS
    $BTTR
    $BYND
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fribourg Paul J bought $10,971,329 worth of shares (156,459 units at $70.12) and sold $14,481 worth of shares (222 units at $65.23), increasing direct ownership by 92% to 29,650 units (SEC Form 4)

    4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)

    3/16/26 4:33:49 PM ET
    $IFF
    Major Chemicals
    Industrials

    Chief Executive Officer Fyrwald J Erik bought $995,204 worth of shares (14,260 units at $69.79), increasing direct ownership by 18% to 91,630 units (SEC Form 4)

    4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)

    3/16/26 4:33:47 PM ET
    $IFF
    Major Chemicals
    Industrials

    PRESIDENT, CEO, EXEC CHAIRMAN Rosensweig Daniel bought $56,360 worth of shares (100,000 units at $0.56), increasing direct ownership by 1% to 7,625,075 units (SEC Form 4)

    4 - CHEGG, INC (0001364954) (Issuer)

    2/18/26 6:30:27 AM ET
    $CHGG
    Other Consumer Services
    Real Estate

    $AYX
    $BPTS
    $BTTR
    $BYND
    SEC Filings

    View All

    $AYX
    $BPTS
    $BTTR
    $BYND
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    SEC Form 6-K filed by GreenPower Motor Company Inc.

    6-K - GREENPOWER MOTOR Co INC. (0001584547) (Filer)

    3/27/26 5:26:28 PM ET
    $GP
    Construction/Ag Equipment/Trucks
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Viant Technology Inc.

    SCHEDULE 13G/A - Viant Technology Inc. (0001828791) (Subject)

    3/27/26 1:52:24 PM ET
    $DSP
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Paymentus Holdings Inc.

    SCHEDULE 13G/A - Paymentus Holdings, Inc. (0001841156) (Subject)

    3/27/26 11:19:17 AM ET
    $PAY
    Real Estate

    Hims & Hers Health upgraded by Citigroup with a new price target

    Citigroup upgraded Hims & Hers Health from Sell to Neutral and set a new price target of $24.00

    3/10/26 8:37:35 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Hims & Hers Health upgraded by BofA Securities with a new price target

    BofA Securities upgraded Hims & Hers Health from Underperform to Neutral and set a new price target of $23.00

    3/10/26 8:37:14 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Hims & Hers Health upgraded by Needham with a new price target

    Needham upgraded Hims & Hers Health from Hold to Buy and set a new price target of $30.00

    3/9/26 11:28:34 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $AYX
    $BPTS
    $BTTR
    $BYND
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Costa Mark J

    4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)

    3/25/26 5:14:10 PM ET
    $IFF
    Major Chemicals
    Industrials

    Amendment: SEC Form 3 filed by new insider Costa Mark J

    3/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)

    3/25/26 5:06:30 PM ET
    $IFF
    Major Chemicals
    Industrials

    SEC Form 4 filed by Okupe Oluyemi

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    3/24/26 6:09:57 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $AYX
    $BPTS
    $BTTR
    $BYND
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ParaZero Issues CEO Letter to Shareholders: Reports Strong Revenue Growth for Full Year 2025

    KFAR SABA, Israel, March 27, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (NASDAQ:PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today issued a Letter to Shareholders from Ariel Aron, Chief Executive Officer. Dear Shareholders and Partners, 2025 will be remembered as a transformative year and a significant strategic turning point for ParaZero. I am writing to you today as we stand at the threshold of a new era. ParaZero has successfully completed a fundamental transformation, evolving from a pioneer in drone safety components into a leader in multi-layered au

    3/27/26 7:00:00 AM ET
    $PRZO
    Military/Government/Technical
    Industrials

    Novo Nordisk's FDA-Approved GLP-1s Now Available With Hims & Hers

    Starting today, eligible customers can access a broad assortment of treatment options, including the only FDA-approved GLP-1 weight loss pill Hims & Hers Health, Inc. (NYSE:HIMS) today announced that a broad assortment of Novo Nordisk's FDA-approved GLP-1 medications are available to eligible customers, including the Wegovy® pill, which is the only FDA-approved GLP-1 weight loss pill.1 As a part of a collaboration with Novo Nordisk, Hims & Hers is making it simpler for customers to access FDA-approved GLP-1 medications which are now available at more affordable prices, with more doses and delivery methods. This expansion makes Hims & Hers the largest global consumer health platform for af

    3/26/26 12:00:00 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market

    Insurance Coverage on Vivos Appliances and Treatment Now Available to a Significant Number of Nevada Patients Previously Unable to Access Coverage Concurrently, Vivos Implements Cost Reduction Initiatives Related to Legacy Business Model to Focus on Scaling its Medical Affiliation Distribution Model LITTLETON, Colo., March 26, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associated chronic health conditions, including obstructive sleep apnea (OSA), today announced that physician-owned professional entities supported by t

    3/26/26 8:45:00 AM ET
    $VVOS
    Medical/Dental Instruments
    Health Care

    $AYX
    $BPTS
    $BTTR
    $BYND
    Leadership Updates

    Live Leadership Updates

    View All

    Hims & Hers Names Kathryn Beiser as Chief Communications Officer

    The global communications leader, who previously held roles at Eli Lilly and Kaiser Permanente, joins the world's leading consumer health platform in its next phase of growth Hims & Hers Health, Inc. (NYSE:HIMS), the leading global health and wellness platform, today announced the appointment of Kathryn Beiser as Chief Communications Officer. In this role, Beiser will lead external and internal communications for the company as it enters a new phase of domestic and international growth. In her role as CCO, Beiser will report to CEO Andrew Dudum and focus on continuing to build the Hims & Hers brand and reputation while helping the industry understand the company's expansive vision for the

    3/10/26 8:08:00 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    ParaZero Strengthens Global Sales Leadership with Appointment of Bat-Sheva Noy as VP

    Kfar Saba, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (NASDAQ:PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, recently announced the appointment of Bat-Sheva Noy as its new Vice President of Global Sales. Ms. Noy brings more than 20 years of extensive commercial and leadership experience, with particular expertise in strategic planning, market access, and leading cross-functional teams. Most recently, from 2020 to 2025, she served as the Business Unit Lead for Rare Diseases at Pfizer Israel ((a subsidiary of Pfizer Inc., NYSE:PFE). In that

    3/4/26 8:32:00 AM ET
    $PFE
    $PRZO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Military/Government/Technical
    Industrials

    Military UAV Sector Forecast to Surpass $40+ Billion as Modern Warfare Evolves

    NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Unmanned aerial vehicles (UAVs), commonly known as drones, have become a transformative technology in modern defense and military operations, reshaping strategies from reconnaissance to precision strike capabilities. Military drones offer armed forces enhanced situational awareness, reduced risk to personnel, and cost-efficient mission profiles across surveillance, target acquisition, logistics, and electronic warfare. As autonomous systems incorporating artificial intelligence and advanced sensor suites continue to mature, they are increasingly integral to networked battlefield operations and force multiplie

    2/19/26 8:30:00 AM ET
    $NOC
    $PRZO
    $UAVS
    Industrial Machinery/Components
    Industrials
    Military/Government/Technical
    Aerospace

    $AYX
    $BPTS
    $BTTR
    $BYND
    Financials

    Live finance-specific insights

    View All

    Beyond Meat® to Delay Reporting Fourth Quarter and Full Year 2025 Financial Results Until March 31, 2026

    EL SEGUNDO, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ:BYND), otherwise known as Beyond The Plant Protein Company™ (the "Company"), announced today that it is rescheduling the reporting of its financial results for the fourth quarter and full year ended December 31, 2025 until Tuesday, March 31, 2026 after market close. As previously announced, the Company is in the process of completing its fourth quarter and year-end financial close procedures and in addition to other previously identified material weaknesses, the Company determined that a material weakness in internal control over financial reporting existed as of December 31, 2025, related to controls associa

    3/25/26 8:30:00 AM ET
    $BYND
    Packaged Foods
    Consumer Staples

    Beyond Meat® Reports Delay of Annual Report on Form 10-K for the Full Year Ended December 31, 2025

    EL SEGUNDO, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ:BYND) ("Beyond Meat" or "the Company"), a leader in plant-based meat, announced today that it will delay the filing of its Annual Report on Form 10-K for the full year ended December 31, 2025. The filing is delayed because the Company requires additional time to complete a review and analysis related to its inventory balances, including amounts recorded for the provision of excess and obsolete inventory. The Company continues to work diligently to complete its fourth quarter and full year financial close procedures and has not yet made a determination regarding the potential impact on its financial statements

    3/16/26 4:05:00 PM ET
    $BYND
    Packaged Foods
    Consumer Staples

    Viant Technology Announces Fourth Quarter and Full Year 2025 Financial Results

    Signed multi-year partnership with WHOOP, the human performance company behind world-class wearable technology Achieved record results across key metrics Generated record quarterly CTV advertiser spend(1), accounting for 46% of total ad spend in the fourth quarter Viant Technology Inc. (NASDAQ:DSP), a leader in AI-powered programmatic advertising, today reported financial results for its fourth quarter and full year ended December 31, 2025. "Viant delivered record fourth quarter and full year results, with revenue, contribution ex-TAC and adjusted EBITDA surpassing the high end of our guidance for the quarter," said Tim Vanderhook, Co-Founder and CEO, Viant. "Looking forward, we see

    3/11/26 4:05:00 PM ET
    $DSP
    Computer Software: Programming Data Processing
    Technology

    $AYX
    $BPTS
    $BTTR
    $BYND
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Paymentus Holdings Inc.

    SC 13G - Paymentus Holdings, Inc. (0001841156) (Subject)

    12/10/24 5:08:45 PM ET
    $PAY
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Viant Technology Inc.

    SC 13D/A - Viant Technology Inc. (0001828791) (Subject)

    12/6/24 4:08:19 PM ET
    $DSP
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Maravai LifeSciences Holdings Inc.

    SC 13G/A - MARAVAI LIFESCIENCES HOLDINGS, INC. (0001823239) (Subject)

    11/14/24 7:49:19 PM ET
    $MRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care